LAVA Medtech Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LVAC research report →
About the company
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations.
- CEO
- Anthony Natale
- IPO
- 2021
- HQ
- Waltham, MA, US
Price Chart
- Market Cap
- $149.93M
- P/E
- 33.65
- P/S
- 0.00
- P/B
- 1.29
- EV/EBITDA
- -95.31
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 3.96%
- ROIC
- -1.26%
- Revenue
- $0 · 0.00%
- Net Income
- $4.50M · -74.93%
- EPS
- $0.31 · -75.20%
- Op Income
- $-1,561,000
- FCF YoY
- 35.94%
- 52W High
- $10.85
- 52W Low
- $9.94
- 50D MA
- $10.42
- 200D MA
- $10.23
- Beta
- 0.00
- Avg Volume
- 44.33K
Get TickerSpark's AI analysis on LVAC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 21 | van der Velden Peter | other | 0 |
| Oct 26, 21 | LaPorte Fritz L | other | 0 |
| Oct 26, 21 | Natale Anthony | other | 0 |
Our LVAC coverage
Recent articles, reports, and earnings notes.
No research on LVAC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LVAC report →Similar companies
Peers in the same neighborhood.